Market Overview:
The global opioids market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of chronic pain, rising geriatric population, and growing demand for pain relief medications. The opioids market is segmented on the basis of type into oxycodone, hydromorphone, codeine, fentanyl, and other opioids. The oxycodone segment is expected to account for the largest share of the global opioids market in 2018. This segment is also projected to grow at a CAGR of 4% during the forecast period from 2018 to 2030. The hydromorphone segment is projected to grow at a CAGR of 5% during the same period owing to its high potency and fast-acting nature compared with other opioid types. On the basis of application,the global opioids marketis divided into pain relief, anesthesia,, cough suppression,, diarrhea suppression,, deaddiction,, and others (including obstetrics/gynecology). In terms of value,.
Product Definition:
Opioids are a group of drugs that includes the illegal drug heroin as well as prescription pain relievers such as oxycodone, morphine, and codeine. Opioids are used to relieve pain.
Oxycodone:
Oxycodone is a drug that is mainly used to relieve pain. It contains an opioid which affects the body’s endorphins resulting in reduced pain. Oxycodone can be administered through various routes including oral, intravenous, and intramuscular depending on the site of action required for treatment.
Hydromorphone:
Hydromorphone is a powerful opioid analgesic drug, which is used to treat severe pain. It has the ability to alleviate chronic as well as acute pain and can be used in cases of cancer-induced nausea and vomiting.
Application Insights:
The pain relief application segment led the global market in 2017 and is projected to continue its dominance over the forecast period. The rising prevalence of chronic pain due to cancer, arthritis, and other diseases is anticipated to be a major factor driving the segment growth during the forecast period. Furthermore, increasing awareness about opioid-based analgesic drugs among physicians and patients for relieving chronic as well as acute pain is expected to further propel their demand globally.
Anesthesia application was one of the prominent segments in 2017 owing to high usage rates of opioids during surgeries for preventing anxiety among patients coupled with an increase in surgical procedures worldwide that require anesthesia will drive its consumption rate globally over next seven years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to presence of a large number of opioid-containing products, high per capita consumption, and increasing awareness regarding their side effects. In addition, government initiatives for controlling addiction are also expected to contribute toward growth in this region.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising incidence of chronic pain and deaddiction among patients suffering from cancer as well as other diseases resulting from rapid urbanization and growing population especially in China & India. Moreover, economic development coupled with improving healthcare infrastructure will also boost demand for these drugs over the coming years.
Growth Factors:
- Increasing prevalence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages. Opioids are one of the most effective treatments for chronic pain.
- Rising awareness about opioids: There has been a growing awareness about the benefits and risks of opioids in recent years. This has led to an increase in prescriptions for opioids.
- Growing demand for abuse-deterrent formulations: Opioids are prone to abuse and addiction. Abuse-deterrent formulations help reduce this risk by making it harder to misuse or divert these drugs illegally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Opioids Market Research Report
By Type
Oxycodone, Hydromorphone, Codeine, Fentanyl, Other
By Application
Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction, Others
By Companies
Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Opioids Market Report Segments:
The global Opioids market is segmented on the basis of:
Types
Oxycodone, Hydromorphone, Codeine, Fentanyl, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
Highlights of The Opioids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
- By Application:
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Deaddiction
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Opioids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Opioids are a class of drugs that include morphine, codeine, and fentanyl. Opioids work by binding to opioid receptors in the brain and spinal cord. This blocks pain signals from being sent to the brain, which can relieve pain.
Some of the major players in the opioids market are Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet.
The opioids market is expected to register a CAGR of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Opioids Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Opioids Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Opioids Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Opioids Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Opioids Market Size & Forecast, 2018-2028
4.5.1 Opioids Market Size and Y-o-Y Growth
4.5.2 Opioids Market Absolute $ Opportunity
Chapter 5 Global Opioids Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Opioids Market Size Forecast by Type
5.2.1 Oxycodone
5.2.2 Hydromorphone
5.2.3 Codeine
5.2.4 Fentanyl
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Opioids Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Opioids Market Size Forecast by Applications
6.2.1 Pain Relief
6.2.2 Anesthesia
6.2.3 Cough Suppression
6.2.4 Diarrhea Suppression
6.2.5 Deaddiction
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Opioids Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Opioids Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Opioids Analysis and Forecast
9.1 Introduction
9.2 North America Opioids Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Opioids Market Size Forecast by Type
9.6.1 Oxycodone
9.6.2 Hydromorphone
9.6.3 Codeine
9.6.4 Fentanyl
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Opioids Market Size Forecast by Applications
9.10.1 Pain Relief
9.10.2 Anesthesia
9.10.3 Cough Suppression
9.10.4 Diarrhea Suppression
9.10.5 Deaddiction
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Opioids Analysis and Forecast
10.1 Introduction
10.2 Europe Opioids Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Opioids Market Size Forecast by Type
10.6.1 Oxycodone
10.6.2 Hydromorphone
10.6.3 Codeine
10.6.4 Fentanyl
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Opioids Market Size Forecast by Applications
10.10.1 Pain Relief
10.10.2 Anesthesia
10.10.3 Cough Suppression
10.10.4 Diarrhea Suppression
10.10.5 Deaddiction
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Opioids Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Opioids Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Opioids Market Size Forecast by Type
11.6.1 Oxycodone
11.6.2 Hydromorphone
11.6.3 Codeine
11.6.4 Fentanyl
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Opioids Market Size Forecast by Applications
11.10.1 Pain Relief
11.10.2 Anesthesia
11.10.3 Cough Suppression
11.10.4 Diarrhea Suppression
11.10.5 Deaddiction
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Opioids Analysis and Forecast
12.1 Introduction
12.2 Latin America Opioids Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Opioids Market Size Forecast by Type
12.6.1 Oxycodone
12.6.2 Hydromorphone
12.6.3 Codeine
12.6.4 Fentanyl
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Opioids Market Size Forecast by Applications
12.10.1 Pain Relief
12.10.2 Anesthesia
12.10.3 Cough Suppression
12.10.4 Diarrhea Suppression
12.10.5 Deaddiction
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Opioids Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Opioids Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Opioids Market Size Forecast by Type
13.6.1 Oxycodone
13.6.2 Hydromorphone
13.6.3 Codeine
13.6.4 Fentanyl
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Opioids Market Size Forecast by Applications
13.10.1 Pain Relief
13.10.2 Anesthesia
13.10.3 Cough Suppression
13.10.4 Diarrhea Suppression
13.10.5 Deaddiction
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Opioids Market: Competitive Dashboard
14.2 Global Opioids Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Purdue Pharma
14.3.3 Mallinckrodt
14.3.4 Amneal Pharma
14.3.5 Collegium
14.3.6 J&J
14.3.7 Endo
14.3.8 Pfizer
14.3.9 INSYS
14.3.10 Mylan
14.3.11 Hikma
14.3.12 Egalet
